Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Mastectomy patterns among older women with early invasive breast cancer in England and Wales: A population-based cohort study.

Miller K. et al, (2023), J Geriatr Oncol, 14

Evidence into practice: a national cohort study of NICE-recommended oncological drug therapy utilisation among women diagnosed with invasive breast cancer in England.

Gannon MR. et al, (2023), Br J Cancer

Predicting 10-year breast cancer mortality risk in the general female population in England: a model development and validation study.

Clift AK. et al, (2023), Lancet Digit Health, 5, e571 - e581

Ki67 and breast cancer mortality in women with invasive breast cancer.

Probert J. et al, (2023), JNCI Cancer Spectr, 7

Completeness of endocrine therapy information in the Primary Care Prescription Database (PCPD) and secondary care treatment datasets: A national population-based cohort study using routine healthcare data.

Gannon MR. et al, (2023), Cancer Epidemiol, 86

Patterns of chemotherapy use and outcomes in advanced non-small cell lung cancer by age in England: A retrospective analysis of the population-based Systemic Anti-Cancer Treatment (SACT) dataset.

Pilleron S. et al, (2023), J Geriatr Oncol, 14

Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study.

Taylor C. et al, (2023), BMJ, 381

Risk of breast cancer death after a diagnosis of early invasive breast cancer.

MacKenzie M. et al, (2023), BMJ, 381

Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study.

Dave RV. et al, (2023), Breast cancer research and treatment, 199, 265 - 279

Variation in Rates of Post-Mastectomy Radiotherapy Among Women with Early Invasive Breast Cancer in England and Wales: A Population-Based Cohort Study.

Miller K. et al, (2023), Clin Oncol (R Coll Radiol)

Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study.

Clift AK. et al, (2023), BMJ, 381

Radiotherapy to regional nodes in early breast cancer: Individual-patient-data meta-analysis of 14,324 women in 16 trial

Taylor CAROLYN., (2023), The Lancet

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk None. and Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) None., (2023), Lancet, 401, 1277 - 1292

Concordance of cancer drug therapy information derived from routinely collected hospital admissions data and the Systemic Anti-Cancer Therapy (SACT) dataset, for older women diagnosed with early invasive breast cancer in England

Gannon MR. et al, (2023), Cancer Epidemiology, 83

The Association Between Survival and Receipt of Post-mastectomy Radiotherapy According to Age at Diagnosis Among Women With Early Invasive Breast Cancer: A Population-Based Cohort Study.

Miller K. et al, (2023), Clin Oncol (R Coll Radiol), 35, e265 - e277

Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.

Holt F. et al, (2023), Int J Radiat Oncol Biol Phys

Cytotoxic Chemotherapy for Pancreatic Adenocarcinoma in England 2010-2017: Survival Outcomes.

Wang Z. et al, (2023), Clin Oncol (R Coll Radiol)

Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia.

Clements K. et al, (2022), BMJ Open, 12

The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England.

Gathani T. et al, (2022), Br J Cancer, 1 - 3

The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)-results from the UK Sloane Project.

Shaaban AM. et al, (2022), British journal of cancer

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?